Clinical trial
Comparison of the Efficacy and Safety of Idroflog® (Sodium Hyaluronate and Hydrocortisone) and Sodium Hyaluronate for the Treatment of Dry Eye Disease
NCT05724056 is registered in ClinicalTrials.gov with Alfa Intes Industria Terapeutica Splendore s.r.l. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of the Efficacy and Safety of Idroflog® (Sodium Hyaluronate and Hydrocortisone) and Sodium Hyaluronate for the Treatment of Dry Eye Disease
- Lead sponsor
- Alfa Intes Industria Terapeutica Splendore s.r.l.
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- March 1, 2023
- Completion date
- December 1, 2023
- Enrollment
- 130 (estimated)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
dry eye disease